24 May 2019
("Instem" or the "Company")
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, was notified on 22 May 2019, that Mike McGoun, a Non-Executive Director of the Company, sold 30,000 ordinary shares of 10p each in the Company ("Ordinary Shares") on 21 May 2019 at a price of 347.55 pence per Ordinary Share.
Following the transaction, Mike now has a total interest in 6,786 Ordinary Shares, representing approximately 0.04% of the Company's issued share capital.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|1||Details of the person discharging managerial responsibilities / person closely associated|
|2||Reason for the notification|
|a)||Position/status||Non Executive Director|
|b)||Initial notification /Amendment||Initial|
|3||Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor|
|4||Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted|
|a)||Description of the financial instrument, type of instrument
|Ordinary shares of 10p each
|b)||Nature of the transaction||Sale of ordinary shares|
|c)||Price(s) and volume(s)||Price
- Aggregated volume
|e)||Date of the transaction||21 May 2019|
|f)||Place of the transaction||London Stock Exchange (XLON)|
For further information, please contact:
|Phil Reason, CEO||+44 (0) 1785 825600|
|Nigel Goldsmith, CFO|
|N+1 Singer (Nominated Adviser & Broker)||+44 (0) 207 496 3000|
|Wallbrook Financial PR||Tel: +44 (0) 207 933 8780|
|Paul Cornelius||or email@example.com|
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit instem.com.